The place of ARBs in heart failure therapy: is aldosterone suppression the key?

The place of ARBs in heart failure therapy: is aldosterone suppression the key?

Since the launch of the first orally available angiotensin II (AngII) type 1 receptor (AT 1 R) blocker (ARB) losartan (Cozaar) in the late 1990s, the class of ARBs (or ‘sartans’, short for Angiotensin-RecepTor-ANtagonistS) quickly expanded to include candesartan, eprosartan, irbesartan, valsartan, t...

Full description

Bibliographic Details
Main Authors: Uma Markan, Samhitha Pasupuleti, Celina M. Pollard, Arianna Perez, Beatrix Aukszi, Anastasios Lymperopoulos
Format: Article
Language:English
Published: SAGE Publishing 2019-08-01
Series:Therapeutic Advances in Cardiovascular Disease
Online Access:https://doi.org/10.1177/1753944719868134

Internet

https://doi.org/10.1177/1753944719868134

Similar Items